EcoDrugPlus

Cathepsin K

Ensembl ID : ENSTBEG00000004167
Gene Symbol: CTSK
1 Cross references
240 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSTBEG00000003463
Gene Symbol: CTSS
1 Cross references
269 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSTBEG00000010519
Gene Symbol: CDC7
1 Cross references
208 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSTBEG00000008722
Gene Symbol: CHEK2
1 Cross references
205 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSTBEG00000001733
Gene Symbol: CETP
1 Cross references
137 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSTBEG00000014352
Gene Symbol: CHRM3
1 Cross references
255 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSTBEG00000009206
Gene Symbol: CHRM5
1 Cross references
263 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 3 Subunit

Ensembl ID : ENSTBEG00000011810
Gene Symbol: CHRNA3
1 Cross references
207 Possible Orthologues:

Cholinergic Receptor Nicotinic Beta 4 Subunit

Ensembl ID : ENSTBEG00000012662
Gene Symbol: CHRNB4
1 Cross references
198 Possible Orthologues:

Chymase 1

Ensembl ID : ENSTBEG00000009504
Gene Symbol: CMA1
1 Cross references
292 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSTBEG00000011565
Gene Symbol: F2R
1 Cross references
327 Possible Orthologues:

Coagulation Factor Ii, Thrombin

Ensembl ID : ENSTBEG00000005062
Gene Symbol: F2
1 Cross references
85 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).